Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
40.68
-0.55 (-1.35%)
Jul 11, 2025, 9:38 AM - Market open

Vericel Market Cap

Vericel has a market cap or net worth of $2.05 billion as of July 11, 2025. Its market cap has decreased by -6.37% in one year.

Market Cap
2.05B
Enterprise Value
2.06B
1-Year Change
-6.37%
Ranking
Category
Stock Price
$40.68

Market Cap Chart

Since December 1, 1998, Vericel's market cap has increased from $31.90M to $2.05B, an increase of 6,319.12%. That is a compound annual growth rate of 16.92%.

History

DateMarket Cap% Change
Jul 9, 2025 2.09B -22.92%
Dec 31, 2024 2.71B 59.48%
Dec 29, 2023 1.70B 36.63%
Dec 30, 2022 1.24B -32.39%
Dec 31, 2021 1.84B 31.15%
Dec 31, 2020 1.40B 80.38%
Dec 31, 2019 777.70M 3.12%
Dec 31, 2018 754.20M 296.53%
Dec 29, 2017 190.20M 163.07%
Dec 30, 2016 72.30M 17.75%
Dec 31, 2015 61.40M -15.08%
Dec 31, 2014 72.30M 412.77%
Dec 31, 2013 14.10M -74.46%
Dec 31, 2012 55.20M -21.48%
Dec 30, 2011 70.30M -2.77%
Dec 31, 2010 72.30M 35.14%
Dec 31, 2009 53.50M -20.74%
Dec 31, 2008 67.50M -2.17%
Dec 31, 2007 69.00M -53.19%
Dec 29, 2006 147.40M -32.17%
Dec 30, 2005 217.30M 65.88%
Dec 31, 2004 131.00M 38.19%
Dec 31, 2003 94.80M 321.33%
Dec 31, 2002 22.50M -45.78%
Dec 31, 2001 41.50M 40.20%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 709.79B
Johnson & Johnson 379.41B
AbbVie 344.45B
Novo Nordisk 316.64B
UnitedHealth Group 271.70B
Novartis AG 243.81B
Abbott Laboratories 232.44B
AstraZeneca 223.49B
Market Cap Rankings